• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用HeartMate XVE左心室辅助系统支持的患者中设备故障的识别。

Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.

作者信息

Haft Jonathan W, Suzuki Yoshi, Aaronson Keith D, Dyke David B, Wright Susan, Poirier Victor L, Pagani Francis D

机构信息

Section of Cardiac Surgery, University of Michigan Health Systems, Ann Arbor, Michigan, USA.

出版信息

ASAIO J. 2007 May-Jun;53(3):298-303. doi: 10.1097/MAT.0b013e318033a6b0.

DOI:10.1097/MAT.0b013e318033a6b0
PMID:17515718
Abstract

Predicting end-of-life for left ventricular assist devices is important to determine timing of device removal. A retrospective analysis was performed on 46 patients undergoing implantation of the latest HeartMate XVE from July 1, 2003, through March 31, 2006. Devices were assessed by analysis of motor current waveforms and quantification of the titanium or copper particles within dust localized to the driveline vent filter by optical, polarized light, scanning electron microscopy, and energy dispersive x-ray spectroscopy. Assessments were performed monthly for patients supported > or =330 days or for unexpected device alarms. Thirty-one (67%) patients were supported for <330 days and 15 (33%) were supported for > or =330 days. No malfunctions occurred in patients supported <330 days. For patients supported > or =330 days, five had abnormal current waveforms or copper and titanium dust localized to the vent filter. One underwent urgent transplantation, three underwent device replacement (one death; two ongoing), and one is with ongoing support. Of the remaining 10 patients, seven underwent transplantation; two remain on device; and one died while on left ventricular assist device support. There were no unexpected device failures. Bearing wear of the HeartMate XVE is predictable by analysis of current waveforms or titanium and copper dust within the vent filter.

摘要

预测左心室辅助装置的使用寿命对于确定装置移除时机至关重要。对2003年7月1日至2006年3月31日期间接受最新款HeartMate XVE植入手术的46例患者进行了回顾性分析。通过分析电机电流波形以及采用光学显微镜、偏振光显微镜、扫描电子显微镜和能量色散X射线光谱法对位于驱动线排气过滤器内灰尘中的钛或铜颗粒进行定量分析,来评估装置情况。对于支持时间≥330天的患者或出现意外装置警报的患者,每月进行一次评估。31例(67%)患者的支持时间<330天,15例(33%)患者的支持时间≥330天。支持时间<330天的患者未发生故障。对于支持时间≥330天的患者,5例出现异常电流波形或排气过滤器处有铜和钛灰尘。1例接受了紧急移植,3例进行了装置更换(1例死亡;2例仍在进行中),1例仍在接受支持治疗。在其余10例患者中,7例接受了移植;2例仍使用装置;1例在左心室辅助装置支持下死亡。未出现意外的装置故障。通过分析电流波形或排气过滤器内的钛和铜灰尘,可以预测HeartMate XVE的轴承磨损情况。

相似文献

1
Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.使用HeartMate XVE左心室辅助系统支持的患者中设备故障的识别。
ASAIO J. 2007 May-Jun;53(3):298-303. doi: 10.1097/MAT.0b013e318033a6b0.
2
Improved mechanical reliability of the HeartMate XVE left ventricular assist system.
Ann Thorac Surg. 2006 Oct;82(4):1413-8. doi: 10.1016/j.athoracsur.2006.04.057.
3
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.正中胸骨切开术与肋下切口用于将HeartMate XVE心室辅助装置更换为HeartMate II心室辅助装置的临床经验。
Ann Thorac Surg. 2008 May;85(5):1646-9. doi: 10.1016/j.athoracsur.2008.01.020.
4
Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.HeartMate XVE左心室辅助装置耐久性的提高可提供长达1年的安全机械支持,但在第二年与装置故障的高风险相关。
J Heart Lung Transplant. 2006 Apr;25(4):384-90. doi: 10.1016/j.healun.2005.11.437.
5
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.使用HeartMate II左心室辅助装置作为桥接至移植治疗可提高生存率并降低不良事件发生率。
Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.
6
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.左心室辅助装置植入术后的右心功能障碍:搏动性HeartMate I与轴流式HeartMate II装置的比较
Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.
7
Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.作为移植桥梁的左心室辅助装置不会对心脏移植一年生存率产生不利影响。
J Thorac Cardiovasc Surg. 2008 Sep;136(3):774-7. doi: 10.1016/j.jtcvs.2008.02.087.
8
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.使用Heartmate II左心室辅助装置的患者血栓栓塞风险较低。
J Thorac Cardiovasc Surg. 2008 Nov;136(5):1318-23. doi: 10.1016/j.jtcvs.2007.12.077. Epub 2008 Sep 14.
9
HeartMate VE LVAS design enhancements and its impact on device reliability.HeartMate VE左心室辅助系统的设计改进及其对设备可靠性的影响。
Eur J Cardiothorac Surg. 2004 Jun;25(6):958-63. doi: 10.1016/j.ejcts.2004.03.003.
10
Duration of left ventricular assist device support affects transplant survival.左心室辅助装置支持的持续时间会影响移植存活率。
J Heart Lung Transplant. 1996 Nov;15(11):1151-7.

引用本文的文献

1
Nine Years of Continuous Flow LVAD (HeartMate 3): Survival and LVAD-Related Complications before and after Hospital Discharge.九年持续血流左心室辅助装置(HeartMate 3):出院前后的生存率及与左心室辅助装置相关的并发症
J Cardiovasc Dev Dis. 2024 Sep 30;11(10):301. doi: 10.3390/jcdd11100301.
2
Ethical challenges with the left ventricular assist device as a destination therapy.作为终末期治疗手段的左心室辅助装置所面临的伦理挑战。
Philos Ethics Humanit Med. 2008 Aug 11;3:20. doi: 10.1186/1747-5341-3-20.